Vous n'êtes pas identifié (connexion)

Centre de recherche

CARRIÈRES

Liste des opportunités >

BOTTIN

Gaston De Serres

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Maladies infectieuses et immunitaires
Adresse(s)
2400, avenue d'Estimauville, 3e étage

Québec (Québec)
CANADA G1E 7G9

Téléphone(s)
+1 418-666-7000, poste 274
Télécopieur(s)
+1 418-666-2776
Courriel(s)
Gaston.DeSerres@inspq.qc.ca

Publications récentes (voir toutes les publications de ce chercheur)

De Wals P, Deceuninck G, Lefebvre B, Tsang R, Law D, De Serres G, Gilca V, Gilca R, Boulianne N. Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2017. 64: 1263-1267
Amini R, Gilca R, Douville-Fradet M, Boulianne N, De Serres G. Evaluation of the New World Health Organization Case Definition of Severe Acute Respiratory Infection for Influenza Surveillance During the Peak Weeks of Two Influenza Seasons in Quebec, Canada. Journal of the Pediatric Infectious Diseases Society,  2017. 6: 297-300
Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y, Smith DJ. Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015. The Journal of infectious diseases,  2017. 215: 1059-1099
Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter AL, De Serres G, Drews SJ, Jassem A, Gubbay JB, Charest H, Balshaw R, Bastien N, Li Y, Krajden M. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin,  2017. 22:
Boikos C, Papenburg J, Martineau C, Joseph L, Scheifele D, Chilvers M, Lands LC, De Serres G, Quach C. Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis. Human vaccines & immunotherapeutics,  2017. 13: 1-7
MacDougall DM, Langley JM, Li L, Ye L, MacKinnon-Cameron D, Top KA, McNeil SA, Halperin BA, Swain A, Bettinger JA, Dube E, De Serres G, Halperin SA, Canadian Immunization Research Network. Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program. Vaccine,  2017. 35: 2520-2530
Zafack JG, De Serres G, Rouleau I, Gariepy MC, Gagnon R, Drolet JP, Skowronski DM. Clinical Approach Used in Medical Consultations for Allergic-Like Events Following Immunization: Case Series Report in Relation to Practice Guidelines. The journal of allergy and clinical immunology. In practice,  2017. 5: 718-727.e1
De Serres G, Skowronski DM, Ward BJ, Gardam M, Lemieux C, Yassi A, Patrick DM, Krajden M, Loeb M, Collignon P, Carrat F. Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement. PLoS ONE,  2017. 12: e0163586
Carazo Perez S, De Serres G, Bureau A, Skowronski DM. Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2017. Epub
De Serres G, Skowronski DM. RE: "DETECTABLE RISKS IN STUDIES OF THE FETAL BENEFITS OF MATERNAL INFLUENZA VACCINATION". American journal of epidemiology,  2017. 185: 860-861
© 2017 Tous droits réservés Centre de recherche du CHU de Québec